THREE-DIMENSIONAL MODEL OF METASTATIC TUMOR ANGIOGENESIS IN RESPONSE TO ANTI-ANGIOGENIC FACTOR ANGIOSTATIN

被引:4
|
作者
Zhao, Gaiping [1 ]
Chen, Eryun [2 ]
Yu, Xiaoli [3 ]
Cui, Haipo [1 ]
Lv, Jie [1 ]
Wu, Jie [4 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai 200093, Peoples R China
[2] Univ Shanghai Sci & Technol, Sch Energy & Power Engn, Shanghai 200093, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai 200240, Peoples R China
基金
中国国家自然科学基金;
关键词
Metastatic tumor; angiogenesis; effect of angiostatin; 3D mathematical model; MATHEMATICAL-MODEL; VASCULAR NETWORKS; STRATEGIES; SIMULATION; INHIBITOR; CARCINOMA; FLOW;
D O I
10.1142/S0219519417500944
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Surgeons observed that primary tumors are capable of suppressing the growth of their metastases by generating anti-angiogenic factor angiostatin. A three-dimensional (3D) mathematical model of development of the metastatic tumor vasculature is presented to simulate the morphology and construction of 3D microvascular networks under the inhibitory effect of antiangiogenic factor angiostatin excreted by the primary tumor. The simulation results demonstrate that metastatic tumor microvascular density (MVD) decreases by about 60%, 58% and 52%, respectively, at t = 3, 7 and 14 days under the effect of anti-angiogenic factor angiostatin. The abnormal geometric and morphological features of 3D microvasculature networks inside and outside the metastatic tumor improve in the presence of angiostatin. The present model may allow to simulate experimental tests and may provide theoretical models for clinical research of anti-angiogenic therapy strategies.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs
    Elena Chiavacci
    Milena Rizzo
    Letizia Pitto
    Francesca Patella
    Monica Evangelista
    Laura Mariani
    Giuseppe Rainaldi
    Cytotechnology, 2015, 67 : 969 - 975
  • [32] Three-dimensional tumor angiogenesis mapping in metastatic gastric cancer patients.
    Ko, Jihoon
    Hyung, Sujin
    An, Minae
    Jeon, Noo Li
    Lee, Jeeyun
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Role of the Tumor Microenvironment in Mediating Response to Anti-angiogenic Therapy
    Young D. Jung
    Syed A. Ahmad
    Yoshito Akagi
    Yutaka Takahashi
    Wenbiao Liu
    Niels Reinmuth
    Raymond M. Shaheen
    Fan Fan
    Lee M. Ellis
    Cancer and Metastasis Reviews, 2000, 19 : 147 - 157
  • [34] Role of the tumor microenvironment in mediating response to anti-angiogenic therapy
    Jung, YD
    Ahmad, SA
    Akagi, Y
    Takahashi, Y
    Liu, W
    Reinmuth, N
    Shaheen, RM
    Fan, F
    Ellis, LM
    CANCER AND METASTASIS REVIEWS, 2000, 19 (1-2) : 147 - 157
  • [35] Biomarkers predicting tumor response and evasion to anti-angiogenic therapy
    Jahangiri, Arman
    Aghi, Manish K.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1825 (01): : 86 - 100
  • [36] ANTI-ANGIOGENIC ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR TO TUMOR ANGIOGENESIS IN RETINOBLASTOMA VIA BLOCKADE OF ERK PATHWAY
    Kim, Jin Hyoung
    Song, Hyun Beom
    Kim, Dong Hun
    Park, Kyung Duk
    Kim, Jeong Hun
    NEURO-ONCOLOGY, 2012, 14 : 7 - 7
  • [37] MATHEMATICAL AND NUMERICAL ANALYSIS OF A MODEL FOR ANTI-ANGIOGENIC THERAPY IN METASTATIC CANCERS
    Benzekry, Sebastien
    ESAIM-MATHEMATICAL MODELLING AND NUMERICAL ANALYSIS-MODELISATION MATHEMATIQUE ET ANALYSE NUMERIQUE, 2012, 46 (02): : 207 - 237
  • [38] Visualizing the role of tumor vascular normalization in anti-angiogenic treatment of metastatic cancer
    Zhang, Qingbei
    Bindokas, Vytas
    Shen, Jikun
    Fan, Hanli
    Hoffman, Robert M.
    Xing, H. Rosie
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 245 - 245
  • [39] The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents
    Tufan, AC
    Satiroglu-Tufan, NL
    CURRENT CANCER DRUG TARGETS, 2005, 5 (04) : 249 - 266
  • [40] A chemotherapy combined with an anti-angiogenic drug applied to a cancer model including angiogenesis
    Letellier, Christophe
    Sasmal, Sourav Kumar
    Draghi, Clement
    Denis, Fabrice
    Ghosh, Dibakar
    CHAOS SOLITONS & FRACTALS, 2017, 99 : 297 - 311